vs
CENTURY CASINOS INC（CNTY）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是CENTURY CASINOS INC的1.5倍（$207.3M vs $138.0M），CENTURY CASINOS INC净利率更高（-13.0% vs -62.0%，领先49.0%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 0.2%），CENTURY CASINOS INC自由现金流更多（$-4.7M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 0.7%）
世纪赌场（Century Casinos）是一家博彩企业，总部位于美国科罗拉多州科罗拉多斯普林斯，主营赌场娱乐相关业务，在北美及其他地区运营多处博彩娱乐场所。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
CNTY vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $138.0M | $207.3M |
| 净利润 | $-17.9M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 7.6% | -54.7% |
| 净利率 | -13.0% | -62.0% |
| 营收同比 | 0.2% | 25.9% |
| 净利润同比 | 80.1% | 3.5% |
| 每股收益（稀释后） | $-0.62 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $138.0M | $207.3M | ||
| Q3 25 | $153.7M | $159.9M | ||
| Q2 25 | $150.8M | $166.5M | ||
| Q1 25 | $130.4M | $139.3M | ||
| Q4 24 | $137.8M | $164.6M | ||
| Q3 24 | $155.7M | $139.5M | ||
| Q2 24 | $146.4M | $147.0M | ||
| Q1 24 | $136.0M | $108.8M |
| Q4 25 | $-17.9M | $-128.6M | ||
| Q3 25 | $-10.5M | $-180.4M | ||
| Q2 25 | $-12.3M | $-115.0M | ||
| Q1 25 | $-20.6M | $-151.1M | ||
| Q4 24 | $-90.3M | $-133.2M | ||
| Q3 24 | $-8.1M | $-133.5M | ||
| Q2 24 | $-41.6M | $-131.6M | ||
| Q1 24 | $-13.5M | $-170.7M |
| Q4 25 | 7.6% | -54.7% | ||
| Q3 25 | 11.1% | -106.9% | ||
| Q2 25 | 11.0% | -64.8% | ||
| Q1 25 | 5.5% | -102.6% | ||
| Q4 24 | -45.5% | -74.3% | ||
| Q3 24 | 11.5% | -94.6% | ||
| Q2 24 | 9.7% | -79.1% | ||
| Q1 24 | 6.1% | -151.9% |
| Q4 25 | -13.0% | -62.0% | ||
| Q3 25 | -6.9% | -112.8% | ||
| Q2 25 | -8.2% | -69.0% | ||
| Q1 25 | -15.8% | -108.5% | ||
| Q4 24 | -65.6% | -80.9% | ||
| Q3 24 | -5.2% | -95.7% | ||
| Q2 24 | -28.4% | -89.5% | ||
| Q1 24 | -10.0% | -156.8% |
| Q4 25 | $-0.62 | $-1.28 | ||
| Q3 25 | $-0.35 | $-1.81 | ||
| Q2 25 | $-0.40 | $-1.17 | ||
| Q1 25 | $-0.67 | $-1.57 | ||
| Q4 24 | $-2.95 | $-1.34 | ||
| Q3 24 | $-0.26 | $-1.40 | ||
| Q2 24 | $-1.36 | $-1.52 | ||
| Q1 24 | $-0.45 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $68.9M | $421.0M |
| 总债务越低越好 | $328.9M | — |
| 股东权益账面价值 | $-97.7M | $-80.0M |
| 总资产 | $1.1B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $68.9M | $421.0M | ||
| Q3 25 | $77.7M | $202.5M | ||
| Q2 25 | $85.5M | $176.3M | ||
| Q1 25 | $84.7M | $127.1M | ||
| Q4 24 | $98.8M | $174.0M | ||
| Q3 24 | $118.8M | $150.6M | ||
| Q2 24 | $123.2M | $480.7M | ||
| Q1 24 | $136.5M | $112.3M |
| Q4 25 | $328.9M | — | ||
| Q3 25 | $329.3M | — | ||
| Q2 25 | $328.0M | — | ||
| Q1 25 | $328.8M | — | ||
| Q4 24 | $328.2M | — | ||
| Q3 24 | $327.5M | — | ||
| Q2 24 | $328.8M | — | ||
| Q1 24 | $328.5M | — |
| Q4 25 | $-97.7M | $-80.0M | ||
| Q3 25 | $-78.6M | $9.2M | ||
| Q2 25 | $-66.9M | $151.3M | ||
| Q1 25 | $-54.3M | $144.2M | ||
| Q4 24 | $-34.7M | $255.0M | ||
| Q3 24 | $56.8M | $346.8M | ||
| Q2 24 | $64.6M | $432.4M | ||
| Q1 24 | $106.1M | $140.3M |
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.2B | $1.5B | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.3B | $1.6B | ||
| Q1 24 | $1.3B | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.77× | — | ||
| Q2 24 | 5.09× | — | ||
| Q1 24 | 3.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-114.0K | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-4.7M | $-100.8M |
| 自由现金流率自由现金流/营收 | -3.4% | -48.6% |
| 资本支出强度资本支出/营收 | 3.3% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-15.3M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-114.0K | $-99.8M | ||
| Q3 25 | $144.0K | $-91.4M | ||
| Q2 25 | $11.3M | $-108.3M | ||
| Q1 25 | $-4.6M | $-166.5M | ||
| Q4 24 | $-2.3M | $-79.3M | ||
| Q3 24 | $7.4M | $-67.0M | ||
| Q2 24 | $3.0M | $-77.0M | ||
| Q1 24 | $-11.5M | $-190.7M |
| Q4 25 | $-4.7M | $-100.8M | ||
| Q3 25 | $-4.7M | $-92.7M | ||
| Q2 25 | $5.5M | $-110.7M | ||
| Q1 25 | $-11.3M | $-167.8M | ||
| Q4 24 | $-16.9M | $-79.5M | ||
| Q3 24 | $-2.8M | $-68.6M | ||
| Q2 24 | $-12.9M | $-79.0M | ||
| Q1 24 | $-29.9M | $-193.9M |
| Q4 25 | -3.4% | -48.6% | ||
| Q3 25 | -3.1% | -58.0% | ||
| Q2 25 | 3.6% | -66.5% | ||
| Q1 25 | -8.7% | -120.5% | ||
| Q4 24 | -12.3% | -48.3% | ||
| Q3 24 | -1.8% | -49.2% | ||
| Q2 24 | -8.8% | -53.7% | ||
| Q1 24 | -22.0% | -178.2% |
| Q4 25 | 3.3% | 0.5% | ||
| Q3 25 | 3.2% | 0.8% | ||
| Q2 25 | 3.9% | 1.5% | ||
| Q1 25 | 5.1% | 1.0% | ||
| Q4 24 | 10.7% | 0.1% | ||
| Q3 24 | 6.6% | 1.2% | ||
| Q2 24 | 10.9% | 1.4% | ||
| Q1 24 | 13.5% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNTY
| Gaming | $103.9M | 75% |
| Food And Beverage | $13.2M | 10% |
| Hotel | $10.5M | 8% |
| Other | $5.2M | 4% |
| Pari Mutuel And Sports Betting And Igaming | $5.2M | 4% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
